October 2025
1. HE Y, Ng SM, Ran MS, Wang C, et al
   Beyond criticism, hostility, and emotional overinvolvement: Development and psychometric validation of the Comprehensive Expressed Emotion Scale (CEES) in schizophrenia.
   Compr Psychiatry. 2025;143:152638.
   

   >> Share

   
   September 2025
2. HAO J, Bruggeman R, Veling W, Alizadeh BZ, et al
   The power of youth: Long-term differential effects of developmental functioning trajectory on social functioning, quality of life and personal recovery across the schizophrenia spectrum.
   Compr Psychiatry. 2025;143:152637.
   

   >> Share

   
   August 2025
3. SHEN H, He Y, Zeng R, Ge L, et al
   Aberrant anterior insula underlies interoceptive deficits in alexithymia among schizophrenia patients.
   Compr Psychiatry. 2025;143:152630.
   

   >> Share

   
   
4. DAVID FS, Frank J, Stein F, Meinert S, et al
   Blood-based DNA methylation profiles in major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
   Compr Psychiatry. 2025;143:152629.
   

   >> Share

   
   July 2025
5. FRILEUX S, Faivre N, Urbach M, Vidal N, et al
   Flowers for Algernon: How metacognition affects quality of life in schizophrenia. Structural equation modeling with the FACE-SZ cohort.
   Compr Psychiatry. 2025;142:152622.
   

   >> Share

   
   
6. CHIAPPINI S, Mosca A, Semeraro F, Amerio A, et al
   Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia.
   Compr Psychiatry. 2025;142:152616.
   

   >> Share

   
   April 2025
7. HAZAK A, Liuhanen J, Kantojarvi K, Sulkava S, et al
   Schizophrenia genetic risk and labour market outcomes in the Finnish general population: Are schizophrenia-related traits penalised or rewarded?
   Compr Psychiatry. 2025;140:152600.
   

   >> Share

   
   February 2025
8. ALEKSANDROWICZ A, Kowalski J, Moritz S, Stefaniak I, et al
   A cognitive model of perceptual anomalies: The role of source monitoring, top-down influence and inhibitory processes for hallucinations in schizophrenia spectrum disorders and hallucinatory-like experiences in the general population.
   Compr Psychiatry. 2025;138:152583.
   

   >> Share

   
   October 2024
9. CASTELEIN S, Visser E, Brilman MF, Wardenaar KJ, et al
   Identifying factors strongest associated with clinical, societal and personal recovery in people with psychosis with a long duration of illness.
   Compr Psychiatry. 2024;136:152540.
   

   >> Share

   
   July 2024
10. SHI X, Sun X, Zhang C, Li Z, et al
    Individual stigma in people with severe mental illness: Associations with public stigma, psychological capital, cognitive appraisal and coping orientations.
    Compr Psychiatry. 2024;132:152474.
    

    >> Share

    
    May 2024
11. REDLICH BOSSY M, Muller DR, Niedermoser DW, Burrer A, et al
    Impact of psychopathology on day-to-day living in patients with schizophrenia: A network analysis.
    Compr Psychiatry. 2024;133:152501.
    

    >> Share

    
    
12. DE FILIPPIS R, Aloi M, Liuzza MT, Pugliese V, et al
    Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia.
    Compr Psychiatry. 2024;133:152496.
    

    >> Share

    
    March 2024
13. SAELE RH, Ndetei DM, Mutiso VN, Mamah D, et al
    Epidemiology of DSM-5 psychiatric disorders in Kenyan Youth with Low and High Psychosis Risk.
    Compr Psychiatry. 2024;131:152473.
    

    >> Share

    
    February 2024
14. ANDREO-JOVER J, Wootton O, Fernandez-Jimenez E, Munoz-Sanjose A, et al
    Adverse childhood experiences and cognition: A cross-sectional study in Xhosa people living with schizophrenia and matched medical controls.
    Compr Psychiatry. 2024;130:152459.
    

    >> Share

    
    January 2024
15. ANDREA S, Jan K, Antonin S, Lea J, et al
    Time is the enemy: Negative symptoms are related to even slight differences in the duration of untreated psychosis.
    Compr Psychiatry. 2024;130:152450.
    

    >> Share

    
    December 2023
16. FELSENHEIMER A, Rapp AM
    Proverb comprehension in schizophrenia: A comprehensive review and meta-analysis.
    Compr Psychiatry. 2023;129:152444.
    

    >> Share

    
    November 2023
17. WOLPE N, Vituri A, Jones PB, Shahar M, et al
    The longitudinal structure of negative symptoms in treatment resistant schizophrenia.
    Compr Psychiatry. 2023;128:152440.
    

    >> Share

    
    September 2023
18. SAMI M, Liddle P
    Neurobiology of psychosis and schizophrenia 2022: Nottingham meeting.
    Compr Psychiatry. 2023;127:152415.
    

    >> Share

    
    
19. DIDIER PR, Moore TM, Calkins ME, Prettyman G, et al
    Evaluation of a new intrinsic and extrinsic motivation scale in youth with psychosis spectrum symptoms.
    Compr Psychiatry. 2023;127:152413.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share